Novartis (NYSE:NVS) on Wednesday announced the construction of two new radioligand therapy (RLT) manufacturing facilities in the U.S. as the company faces stiff competition in the radiopharma space. The Swiss drugmaker is establishing a new facility at its Indianapolis site to produce radioisotopes,...